Previous close | 202.90 |
Open | N/A |
Bid | 0.00 |
Ask | 0.00 |
Strike | 640.00 |
Expiry date | 2026-01-16 |
Day's range | 202.90 - 202.90 |
Contract range | N/A |
Volume | |
Open interest | N/A |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning